Sign in Pull a receipt

BBOT

BridgeBio Oncology Therapeutics, Inc.

Healthcare · Biotechnology

$203.98 sample

+2.82 (+1.40%) 1D

Market cap

$1.15T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-15

Alerts

8

Price$203.98 -0.55% 3M daily closessample

208.74191.76

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: Chief Financial Officer
Oct 15SECForm 144 filed
Oct 12INSInsider sell: General Counsel
Oct 01SECForm 144 filed
Sep 25INSInsider sell: Chief Financial Officer
Sep 16INSInsider sell: EVP, Operations
Sep 10INSInsider sell: General Counsel
Sep 04INSInsider sell: 10% owner

Sign up to see the real BBOT record →

Company facts

SEC EDGAR registration

Name: BridgeBio Oncology Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +29sample, -100 to +100
Reporting currency: USD

Who is positioning in BBOT

sample

Insiders: 32 insider transactions over 90 days, net selling, $607.0M
Congress: 4 members traded over 90 days
Institutions · 13F: 36 funds hold $18.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$27.5B +20.6% y/y

Q4 2024Q3 2026

Inventory$15.9B +13.3% y/y

Q4 2024Q3 2026

Accounts receivable$11.7B +7.8% y/y

Q4 2024Q3 2026

Total debt$31.4B +13.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $501.4B -0.1% 3M
Sample peer B: $660.0B +0.3% 3M
Sample peer C: $394.4B +13.4% 3M
Sample peer D: $754.6B -6.0% 3M
Sample peer E: $587.8B -10.7% 3M